Production Method 1

16110-09-1

132308-19-1

881-86-7

Reaction Conditions

1.1 Reagents: Triethylamine Catalysts: Triphenylphosphine ,  Dichlorobis(triphenylphosphine)palladium Solvents: Methanol
1.2 -

Reference

Selective palladium-catalyzed carbonylations of dichloroquinoline and simple dichloropyridines

Najiba, Douja; et al, Tetrahedron Letters, 1999, 40(19), 3719-3722

Methyl 5-chloropyridine-2-carboxylate Raw materials

• 2,5-Dichloropyridine

Methyl 5-chloropyridine-2-carboxylate Preparation Products

• Methyl 5-chloropyridine-2-carboxylate (132308-19-1)
• 2,5-dimethyl pyridine-2,5-dicarboxylate (881-86-7)

• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Methyl 5-chloropyridine-2-carboxylate (CAS No. 132308-19-1): A Key Intermediate in Modern Pharmaceutical Synthesis

Methyl 5-chloropyridine-2-carboxylate (CAS No. 132308-19-1) is a versatile and highly valuable intermediate in the field of pharmaceutical synthesis. This compound, characterized by its chlorinated pyridine core and ester functional group, has garnered significant attention due to its utility in the development of various therapeutic agents. The unique structural features of Methyl 5-chloropyridine-2-carboxylate make it an indispensable building block for medicinal chemists, enabling the construction of complex molecular frameworks with high precision and efficiency.

The chemical structure of Methyl 5-chloropyridine-2-carboxylate consists of a pyridine ring substituted at the 5-position with a chlorine atom and at the 2-position with a carboxylate ester. This arrangement provides multiple reactive sites that can be selectively modified through various organic transformations. The presence of the chloro group enhances the electrophilicity of the pyridine ring, making it susceptible to nucleophilic substitution reactions, while the ester functionality allows for facile hydrolysis or transesterification, offering flexibility in synthetic pathways.

In recent years, Methyl 5-chloropyridine-2-carboxylate has been extensively utilized in the synthesis of bioactive molecules targeting diverse disease mechanisms. One notable area of application is in the development of antiviral agents. The pyridine scaffold is a common motif in many antiviral drugs due to its ability to interact with biological targets such as enzymes and receptors. For instance, studies have demonstrated that derivatives of Methyl 5-chloropyridine-2-carboxylate can be modified to produce inhibitors of viral proteases and polymerases, contributing to the fight against emerging viral threats.

Additionally, this compound has found relevance in the field of anticancer research. The chlorinated pyridine core serves as a privileged structure that can be further functionalized to generate kinase inhibitors and other targeted therapies. Recent advancements in drug design have highlighted the potential of Methyl 5-chloropyridine-2-carboxylate as a precursor for small-molecule drugs that disrupt cancer cell proliferation by inhibiting key signaling pathways. For example, researchers have successfully incorporated this intermediate into molecules that selectively inhibit tyrosine kinases, which are overexpressed in many types of cancer.

The synthesis of Methyl 5-chloropyridine-2-carboxylate itself is an intriguing process that showcases modern synthetic methodologies. Traditional approaches often involve multi-step sequences starting from readily available pyridine derivatives. However, recent innovations have enabled more streamlined routes, often involving catalytic chlorination and esterification steps under mild conditions. These improvements not only enhance yield but also reduce waste, aligning with green chemistry principles. The efficiency of these synthetic strategies has made Methyl 5-chloropyridine-2-carboxylate more accessible for industrial-scale production.

The versatility of Methyl 5-chloropyridine-2-carboxylate extends beyond its role as a synthetic intermediate; it also serves as a platform for exploring novel chemical entities through structure-activity relationship (SAR) studies. By systematically modifying its structure, researchers can gain insights into how different substituents influence biological activity. This approach has been instrumental in optimizing drug candidates for better efficacy and reduced toxicity. For instance, variations in the substitution pattern around the pyridine ring have been shown to modulate binding affinity to biological targets, demonstrating the importance of fine-tuning molecular architecture.

In conclusion, Methyl 5-chloropyridine-2-carboxylate (CAS No. 132308-19-1) represents a cornerstone in modern pharmaceutical synthesis. Its unique structural features and reactivity make it an invaluable tool for medicinal chemists seeking to develop innovative therapeutic agents. As research continues to uncover new applications and synthetic strategies, this compound is poised to remain at the forefront of drug discovery efforts across various therapeutic areas.

• 24484-93-3(methyl 4-chloropyridine-2-carboxylate)
• 109880-43-5(Methyl 4-chloro-6-(hydroxymethyl)picolinate)
• 176977-85-8(methyl 4-chloropyridine-2-carboxylate hydrochloride)
• 116383-98-3(methyl 3-chloropyridine-2-carboxylate)
• 128072-93-5(Ethyl 5-chloro-2-pyridinecarboxylate)
• 1261749-95-4(Methyl 5-chloro-6-methylpicolinate)
• 86873-60-1(5-chloropyridine-2-carboxylic acid)
• 5371-70-0(Dimethyl 4-chloropyridine-2,6-dicarboxylate)
• 5439-08-7(Methyl 3,5-dichloropicolinate)
• 293294-71-0(4-Chloro-6-(methoxycarbonyl)picolinic acid)